Portal:CPTAC/Hallmark/Angiogenesis
From WikiPathways
(Difference between revisions)
(Added descriptive summary) |
Current revision (18:48, 10 October 2019) (view source) (added pathway) |
||
| (One intermediate revision not shown.) | |||
| Line 4: | Line 4: | ||
*[[Pathway:WP2526]] PDGF Pathway | *[[Pathway:WP2526]] PDGF Pathway | ||
*[[Pathway:WP4249]] Hedgehog Signaling Pathway | *[[Pathway:WP4249]] Hedgehog Signaling Pathway | ||
| + | *[[Pathway:WP3888]] VEGFA-VEGFR2 Signaling Pathway | ||
| + | *[[Pathway:WP4397]] Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors | ||
Current revision
Like normal tissues, tumors require nutrients and oxygen and also need to evacuate metabolic wastes and carbon dioxide. This is accomplished by tumor-associated neovasculature. Evidence indicates that the angiogenic switch is governed by countervailing factors that either induce or oppose angiogenesis. Some of these angiogenic regulators are signaling proteins that bind to stimulatory or inhibitory cell-surface receptors displayed by vascular endothelial cells. The well-known prototypes of angiogenesis inducers and inhibitors are vascular endothelial growth factor-A (VEGF-A) and thrombospondin-1 (TSP-1), respectively. (Adapted from Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011)
- Pathway:WP1539 Angiogenesis
- Pathway:WP2526 PDGF Pathway
- Pathway:WP4249 Hedgehog Signaling Pathway
- Pathway:WP3888 VEGFA-VEGFR2 Signaling Pathway
- Pathway:WP4397 Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors
